ArticleFrontiers in immunology2022

A novel ganglioside-related risk signature can reveal the distinct immune landscape of neuroblastoma and predict the immunotherapeutic response.

Jiaxing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.